FDA advisory panel endorses Moderna mRNA flu vaccine that was subject of controversy - statnews.com

1. FDA advisory panel endorses Moderna mRNA flu vaccine that was subject of controversy  statnews.com
2. Moderna's mRNA flu vaccine backed by FDA advisers  Reuters
3. Key FDA committee unanimously recommends its first vaccine since 2023  NPR
4. FDA panel recommends Moderna’s mRNA flu shot for older adults  NBC News
5. Moderna flu vaccine wins unanimous support from FDA panel  BioPharma Dive
6. FDA panel backs first-of-its-kind flu vaccine using mRNA technology  AP News
7. Moderna’s flu candidate sails through FDA advisory committee in unanimous votes  Fierce Biotech
8. FDA panel strongly backs Moderna's mRNA flu vaccine  FirstWord Pharma
9. Moderna Announces FDA Advisory Committee Votes Unanimously in Favor of the Benefit-Risk Profile of mRNA-1010, an Investigational Seasonal Influenza Vaccine  Yahoo Finance

FDA experts endorse Moderna's mRNA seasonal flu shot - pharmaphorum

FDA experts endorse Moderna's mRNA seasonal flu shot  pharmaphorum

FDA Panel Unanimously Backs Moderna’s Breakthrough mRNA Flu Vaccine Amid Political Turbulence - P...

FDA Panel Unanimously Backs Moderna’s Breakthrough mRNA Flu Vaccine Amid Political Turbulence  Pharmacy Times

FDA Advisory Committee Votes Unanimously in Favor of The Benefit-Risk Profile of Moderna's mRNA-1...

FDA Advisory Committee Votes Unanimously in Favor of The Benefit-Risk Profile of Moderna's mRNA-1010 | PharmExec  Pharmaceutical Executive

FDA Advisory Panel Votes 9-0 in Favor of Moderna's mRNA Flu Vaccine, Setting Stage for August Dec...

FDA Advisory Panel Votes 9-0 in Favor of Moderna's mRNA Flu Vaccine, Setting Stage for August Decision  BioPharm International

mRNA Patent Wars Update: Delaware Court Allows Moderna and Pfizer/BioNTech to Assert Laches in GS...

mRNA Patent Wars Update: Delaware Court Allows Moderna and Pfizer/BioNTech to Assert Laches in GSK Patent Infringement Cases  JD Supra

Moderna hires Novartis vet to lead commercial, upsizes role for Hoge as potential launches loom -...

Moderna hires Novartis vet to lead commercial, upsizes role for Hoge as potential launches loom  Fierce Pharma

Why Is Moderna (MRNA) Stock Soaring Today - Yahoo Finance

Why Is Moderna (MRNA) Stock Soaring Today  Yahoo Finance

Quick takes: Moderna mRNA flu vaccine review, NIH award for genital herpes vaccine, malaria monoc...

Quick takes: Moderna mRNA flu vaccine review, NIH award for genital herpes vaccine, malaria monoclonal antibody trial  CIDRAP

FDA, Moderna appear aligned on mRNA flu shot heading into adcomm - BioSpace

FDA, Moderna appear aligned on mRNA flu shot heading into adcomm  BioSpace

Moderna announces executive changes ahead of potential launches - Reuters

Moderna announces executive changes ahead of potential launches  Reuters

Amenable FDA review bodes well for Moderna's mRNA flu shot ahead of adcomm grilling - Fierce Biotech

Amenable FDA review bodes well for Moderna's mRNA flu shot ahead of adcomm grilling  Fierce Biotech

FDA staff scrutinizes evidence supporting Moderna’s flu vaccine - BioPharma Dive

FDA staff scrutinizes evidence supporting Moderna’s flu vaccine  BioPharma Dive

Moderna’s mRNA flu shot wins unanimous support at FDA adcomm in rebuke of former leadership - Bio...

Moderna’s mRNA flu shot wins unanimous support at FDA adcomm in rebuke of former leadership  BioSpace

Moderna interested in Germany production, sees opportunity in BioNTech closures, says CEO - Reuters

Moderna interested in Germany production, sees opportunity in BioNTech closures, says CEO  Reuters

Moderna flu shot data may support use in older adults, US FDA staff says - Reuters

Moderna flu shot data may support use in older adults, US FDA staff says  Reuters

SpaceX, Western Digital, Moderna, and More Stocks That Explain Today’s Market - Barron's

SpaceX, Western Digital, Moderna, and More Stocks That Explain Today’s Market  Barron's

Moderna’s mRNA flu vaccine gets thumbs up from federal vaccine panel - CIDRAP

Moderna’s mRNA flu vaccine gets thumbs up from federal vaccine panel  CIDRAP

FDA Votes in Favor of Benefit-Risk Profile for Moderna’s Flu Vaccine - WSJ

FDA Votes in Favor of Benefit-Risk Profile for Moderna’s Flu Vaccine  WSJ

FDA advisors unanimously vote to approve Moderna’s mRNA after agency drama - Ars Technica

FDA advisors unanimously vote to approve Moderna’s mRNA after agency drama  Ars Technica

This Week at FDA: New international partnerships, UniQure and Moderna reversals, and more - RAPS.org

This Week at FDA: New international partnerships, UniQure and Moderna reversals, and more  RAPS.org

FDA AdCom unanimously backs Moderna’s mFlusiva - The Pharma Letter

FDA AdCom unanimously backs Moderna’s mFlusiva  The Pharma Letter

FDA Files Concerns Over Missing Data for Moderna’s mRNA Flu Shot: Report - Pharmaceutical Executive

FDA Files Concerns Over Missing Data for Moderna’s mRNA Flu Shot: Report  Pharmaceutical Executive

Moderna (MRNA) Soars 11% Ahead of Investor Day - Yahoo Finance

Moderna (MRNA) Soars 11% Ahead of Investor Day  Yahoo Finance

FDA panel considers a first-of-its-kind flu vaccine using mRNA technology - The Guardian

FDA panel considers a first-of-its-kind flu vaccine using mRNA technology  The Guardian

US FDA advisers vote in favor of Moderna's flu vaccine - Reuters

US FDA advisers vote in favor of Moderna's flu vaccine  Reuters

FDA appears open to Moderna’s flu vaccine ahead of adcomm - statnews.com

FDA appears open to Moderna’s flu vaccine ahead of adcomm  statnews.com

Moderna just got a signal investors can’t ignore - Yahoo Finance

Moderna just got a signal investors can’t ignore  Yahoo Finance

Pharmalittle: We're reading about an FDA review of Moderna's flu shot, J&J's focus on cancer, and...

Pharmalittle: We're reading about an FDA review of Moderna's flu shot, J&J's focus on cancer, and more  statnews.com

Moderna (MRNA) Surges 6.3%: Is This an Indication of Further Gains? - Yahoo Finance

Moderna (MRNA) Surges 6.3%: Is This an Indication of Further Gains?  Yahoo Finance

Moderna (MRNA) Climbs 6% as Firm Eyes Launch of 3 Vaccines - Yahoo Finance

Moderna (MRNA) Climbs 6% as Firm Eyes Launch of 3 Vaccines  Yahoo Finance

FDA panel gives nod to Moderna flu shot - The Hill

FDA panel gives nod to Moderna flu shot  The Hill

FDA Advisory Panel Convenes Today to Weigh Moderna's mRNA-Based Flu Vaccine - BioPharm International

FDA Advisory Panel Convenes Today to Weigh Moderna's mRNA-Based Flu Vaccine  BioPharm International

The Surprising FDA View That Sent Moderna Stock Flying - Investor's Business Daily

The Surprising FDA View That Sent Moderna Stock Flying  Investor's Business Daily

FDA vaccine panel set to review Moderna mRNA flu shot - The Hill

FDA vaccine panel set to review Moderna mRNA flu shot  The Hill

Moderna builds commercial muscle as new launches loom - pharmaphorum

Moderna builds commercial muscle as new launches loom  pharmaphorum

Moderna Extends Rally as FDA Advisory Panel Reviews Flu Vaccine Application (MRNA) - Yahoo Finance

Moderna Extends Rally as FDA Advisory Panel Reviews Flu Vaccine Application (MRNA)  Yahoo Finance

FDA flags 'evidence gaps' for Moderna's mRNA flu shot, but no 'major' concerns - FirstWord Pharma

FDA flags 'evidence gaps' for Moderna's mRNA flu shot, but no 'major' concerns  FirstWord Pharma

Moderna’s FDA adcomm, IPO mania, biopharma layoffs, more - BioSpace

Moderna’s FDA adcomm, IPO mania, biopharma layoffs, more  BioSpace

Biopharma bites: Moderna welcomes ex-BMS, Novartis exec, plus heart benefits from COVID-19 shots ...

Biopharma bites: Moderna welcomes ex-BMS, Novartis exec, plus heart benefits from COVID-19 shots  FirstWord Pharma

Moderna adds commercial chief, expands Stephen Hoge's role; Reunion Neuroscience CEO departs - En...

Moderna adds commercial chief, expands Stephen Hoge's role; Reunion Neuroscience CEO departs  Endpoints News

Moderna's mRNA flu vaccine faces FDA advisory panel scrutiny - Yahoo

Moderna's mRNA flu vaccine faces FDA advisory panel scrutiny  Yahoo

First-of-its-kind flu shot may be approved for older adults - NewsNation

First-of-its-kind flu shot may be approved for older adults  NewsNation

FDA review raises questions ahead of panel meeting on Moderna’s mRNA flu vaccine - The Pharma Letter

FDA review raises questions ahead of panel meeting on Moderna’s mRNA flu vaccine  The Pharma Letter

New Moderna mRNA flu vaccine could offer broader, longer-lasting protection - WBAY

New Moderna mRNA flu vaccine could offer broader, longer-lasting protection  WBAY

Table turned, Moderna’s high-fi flu shot plays well at adcom - BioWorld News

Table turned, Moderna’s high-fi flu shot plays well at adcom  BioWorld News

Moderna Stock Surges As Federal Health Regulators Clear Milestone Older Adult Flu Vaccine Data - ...

Moderna Stock Surges As Federal Health Regulators Clear Milestone Older Adult Flu Vaccine Data  TIKR.com

Moderna Announces Organizational Changes to Prepare for Multiple Product Launches in 2027 and 202...

Moderna Announces Organizational Changes to Prepare for Multiple Product Launches in 2027 and 2028  Yahoo Finance

Moderna spotlights mRNA, AI and robotics at 2026 'Science Day' - Stock Titan

Moderna spotlights mRNA, AI and robotics at 2026 'Science Day'  Stock Titan

FDA panel supports first mRNA-based flu vaccine - National Desk

FDA panel supports first mRNA-based flu vaccine  National Desk

Moderna Is Up 94% This Year: Is It Outperforming Other Vaccine Stocks Like Pfizer and Novavax? - ...

Moderna Is Up 94% This Year: Is It Outperforming Other Vaccine Stocks Like Pfizer and Novavax?  24/7 Wall St.

Doctor explains Moderna's candidate for first MRNA flu shot - WCVB

Doctor explains Moderna's candidate for first MRNA flu shot  WCVB

No Myocarditis Signal Or Major Deficiencies In Moderna mRNA Flu Vaccine That Received RTF - Citel...

No Myocarditis Signal Or Major Deficiencies In Moderna mRNA Flu Vaccine That Received RTF  Citeline News & Insights

Moderna flu shot data may support use in older adults, US FDA staff says - Yahoo

Moderna flu shot data may support use in older adults, US FDA staff says  Yahoo

Moderna readies leadership for up to three new vaccines by 2028 - Stock Titan

Moderna readies leadership for up to three new vaccines by 2028  Stock Titan

Moderna stock rises on FDA flu vaccine advisory panel review - Investing.com

Moderna stock rises on FDA flu vaccine advisory panel review  Investing.com

Why Is Moderna (MRNA) Stock Rocketing Higher Today - Yahoo Finance

Why Is Moderna (MRNA) Stock Rocketing Higher Today  Yahoo Finance

Another shot: Moderna flu vaccine re-upped in adcom - BioWorld News

Another shot: Moderna flu vaccine re-upped in adcom  BioWorld News

Moderna hires commercial chief ahead of multiple product launches - Seeking Alpha

Moderna hires commercial chief ahead of multiple product launches  Seeking Alpha

Moderna prepares for product launches following organizational changes - medwatch.com

Moderna prepares for product launches following organizational changes  medwatch.com

Moderna (MRNA) Climbs 7.5% Ahead of Next Week’s Key Updates - Yahoo Finance

Moderna (MRNA) Climbs 7.5% Ahead of Next Week’s Key Updates  Yahoo Finance

Recon: FDA approves Merck's Welireg-Keytruda combo for kidney cancer; FDA staff signal support fo...

Recon: FDA approves Merck's Welireg-Keytruda combo for kidney cancer; FDA staff signal support for Moderna’s flu shot in older adults  RAPS.org

FDA advisers back Moderna's flu vaccine for older adults, 9-0 - Stock Titan

FDA advisers back Moderna's flu vaccine for older adults, 9-0  Stock Titan

Moderna Stock On Fire: Up 34% With 5-Day Winning Streak - Trefis

Moderna Stock On Fire: Up 34% With 5-Day Winning Streak  Trefis

FDA panel recommends mRNA flu vaccine for older adults - The Hill

FDA panel recommends mRNA flu vaccine for older adults  The Hill

Moderna prepares for multiple product launches - The Pharma Letter

Moderna prepares for multiple product launches  The Pharma Letter

Moderna seeks FDA approval for its new flu shots that us MRNA technology - Yahoo

Moderna seeks FDA approval for its new flu shots that us MRNA technology  Yahoo

ASCO: Moderna’s mRNA-based melanoma vaccine shows ‘encouraging’ 5-year survival - BioSpace

ASCO: Moderna’s mRNA-based melanoma vaccine shows ‘encouraging’ 5-year survival  BioSpace

Moderna (MRNA) Stock Looks Slightly Overvalued After Recent Rebound In Mixed Return Picture - Yah...

Moderna (MRNA) Stock Looks Slightly Overvalued After Recent Rebound In Mixed Return Picture  Yahoo Finance

Moderna gains unanimous FDA panel endorsement of flu vaccine - Seeking Alpha

Moderna gains unanimous FDA panel endorsement of flu vaccine  Seeking Alpha

Moderna stock hits 52-week high at $59.57 - Investing.com

Moderna stock hits 52-week high at $59.57  Investing.com

Moderna Strengthens Commercial Strategy As Pipeline Advances - Benzinga

Moderna Strengthens Commercial Strategy As Pipeline Advances  Benzinga

Moderna Stock Rockets 34% With 5-Day Winning Streak - Trefis

Moderna Stock Rockets 34% With 5-Day Winning Streak  Trefis

Moderna and other groups get $60 million to develop Ebola vaccine - Reuters

Moderna and other groups get $60 million to develop Ebola vaccine  Reuters

US FDA advisers vote in favor of Moderna’s flu vaccine - 1470 & 100.3 WMBD

US FDA advisers vote in favor of Moderna’s flu vaccine  1470 & 100.3 WMBD

Moderna's Flu Vaccine Clears Key FDA Panel Vote As Advisory Committee Backs Shot 9-0 - Benzinga

Moderna's Flu Vaccine Clears Key FDA Panel Vote As Advisory Committee Backs Shot 9-0  Benzinga

Moderna hits three-month high after FDA review for flu shot (update) - Seeking Alpha

Moderna hits three-month high after FDA review for flu shot (update)  Seeking Alpha

Moderna (MRNA) Shares Rise Following FDA Advisory Committee Appr - GuruFocus

Moderna (MRNA) Shares Rise Following FDA Advisory Committee Appr  GuruFocus

MRNA Up as Influenza Vaccine Wins Unanimous FDA Advisory Panel Backing - TradingView

MRNA Up as Influenza Vaccine Wins Unanimous FDA Advisory Panel Backing  TradingView

FDA panel backs Moderna’s flu vaccine for older adults - Investing.com

FDA panel backs Moderna’s flu vaccine for older adults  Investing.com

Moderna's mRNA flu vaccine faces FDA advisory panel scrutiny - TradingView

Moderna's mRNA flu vaccine faces FDA advisory panel scrutiny  TradingView

FDA Panel Set To Debate Moderna Flu Shot - Benzinga

FDA Panel Set To Debate Moderna Flu Shot  Benzinga

UBS Lifts Valuation On Moderna, Inc. (MRNA) Ahead of Key Pipeline Catalysts - Yahoo Finance

UBS Lifts Valuation On Moderna, Inc. (MRNA) Ahead of Key Pipeline Catalysts  Yahoo Finance

Moderna shares gain after FDA staff backs flu vaccine data - Investing.com

Moderna shares gain after FDA staff backs flu vaccine data  Investing.com

Moderna Secures Favorable FDA Panel Recommendation for mRNA Flu Vaccine - marketscreener.com

Moderna Secures Favorable FDA Panel Recommendation for mRNA Flu Vaccine  marketscreener.com

Moderna to Present at Upcoming Conference in June 2026 - Yahoo Finance

Moderna to Present at Upcoming Conference in June 2026  Yahoo Finance

Moderna gets $50 million to develop mRNA Ebola vaccine against Bundibugyo - Ars Technica

Moderna gets $50 million to develop mRNA Ebola vaccine against Bundibugyo  Ars Technica

Moderna Launches Moderna Direct with “eCommerce Powered by FFF Enterprises™” - Yahoo Finance

Moderna Launches Moderna Direct with “eCommerce Powered by FFF Enterprises™”  Yahoo Finance

Moderna (MRNA) Flu Vaccine Benefits Confirmed by FDA Advisers - GuruFocus

Moderna (MRNA) Flu Vaccine Benefits Confirmed by FDA Advisers  GuruFocus

Moderna (MRNA) Receives Positive FDA Advisory Votes for Flu Vacc - GuruFocus

Moderna (MRNA) Receives Positive FDA Advisory Votes for Flu Vacc  GuruFocus

Moderna (MRNA) Receives Positive Advisory Committee Vote for Inf - GuruFocus

Moderna (MRNA) Receives Positive Advisory Committee Vote for Inf  GuruFocus

SpaceX and Moderna among market cap stock movers on Tuesday - Investing.com

SpaceX and Moderna among market cap stock movers on Tuesday  Investing.com